American Effectively Company (NYSE:AMWL) Q2 2025 Earnings Convention Name August 5, 2025 5:00 PM ET
Firm Contributors
Ido Schoenberg – Chairman & CEO
Mark J. Hirschhorn – Govt VP, COO & CFO
Sue Dooley – Head of Investor Relations
Convention Name Contributors
Eric R. Percher – Nephron Analysis LLC
Jack A. Senft – UBS Funding Financial institution, Analysis Division
Jailendra P. Singh – Truist Securities, Inc., Analysis Division
Lucas Cole Romanski – TD Cowen, Analysis Division
Matthew Dineen Shea – Needham & Firm, LLC, Analysis Division
Stanislav Berenshteyn – Wells Fargo Securities, LLC, Analysis Division
Yong Solar Park – Morgan Stanley, Analysis Division
Operator
Good day, and thanks for standing by. Welcome to the Amwell Second Quarter 2025 Earnings Convention Name. [Operator Instructions] Please be suggested that as we speak’s convention is being recorded.
I might now like handy the convention over to your speaker as we speak, Sue Dooley, Head of Investor Relations.
Sue Dooley
Good day, everybody. Welcome to Amwell’s convention name to debate our second fiscal quarter of 2025. That is Sue Dooley of Amwell Investor Relations. Becoming a member of me as we speak are Amwell’s Chairman and CEO, Dr. Ido Schoenberg; and Mark Hirschhorn, our CFO and Chief Working Officer.
Earlier as we speak, we distributed a press launch detailing our announcement. Our earnings report is posted on our web site at buyers.amwell.com and can also be out there via regular information sources. This convention name is being webcast stay on the IR web page of our web site, the place a replay shall be archived.
Earlier than we start our ready remarks, I might wish to take this chance to remind you that through the name, we’ll make forward- trying statements concerning projected working outcomes and anticipated market alternatives. This forward-looking data is topic to the dangers and uncertainties described in our filings with the SEC and precise outcomes or occasions could differ materially. Besides as required
